Search research articles
Contact Us
Filters
Showing results (21-30 of 23) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 23 results.
Shock (Augusta, Ga.)
|
September 25, 2025
Blood Biomarker and Raman Analysis of Leukocytes in the Multicenter Intelligence Trials: At the Intensive Care Unit (Intelligence-1) and the Emergency Department (Intelligence-2)
Evangelos J Giamarellos-Bourboulis, Daniel Thomas-Rüddel, Aikaterini Pistiki, et al.
Infection
|
December 8, 2025
Think sepsis, write sepsis, code sepsis - patient characteristics associated with sepsis (under-)coding in administrative health data
Daniel Thomas-Rüddel, Norman Rose, Carolin Fleischmann-Struzek, et al.
Journal of Clinical Microbiology
|
April 23, 2026
Diagnostic performance of β-(1→3)-D-glucan, two <i>Candida</i> antigen, and five anti-<i>Candida</i> antibody assays in ICU patients with sepsis and high risk for invasive candidiasis: a secondary endpoint of the CandiSep randomized clinical trial
Lea Standl, Timo Huber, Frank Bloos, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 23) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 23 results.
Shock (Augusta, Ga.)
|
September 25, 2025
Blood Biomarker and Raman Analysis of Leukocytes in the Multicenter Intelligence Trials: At the Intensive Care Unit (Intelligence-1) and the Emergency Department (Intelligence-2)
Evangelos J Giamarellos-Bourboulis, Daniel Thomas-Rüddel, Aikaterini Pistiki, et al.
Infection
|
December 8, 2025
Think sepsis, write sepsis, code sepsis - patient characteristics associated with sepsis (under-)coding in administrative health data
Daniel Thomas-Rüddel, Norman Rose, Carolin Fleischmann-Struzek, et al.
Journal of Clinical Microbiology
|
April 23, 2026
Diagnostic performance of β-(1→3)-D-glucan, two <i>Candida</i> antigen, and five anti-<i>Candida</i> antibody assays in ICU patients with sepsis and high risk for invasive candidiasis: a secondary endpoint of the CandiSep randomized clinical trial
Lea Standl, Timo Huber, Frank Bloos, et al.
Page
of 3